J. Rabine

发表

Diagnosis and management of supraesophageal complications of reflux disease

T. Nostrant, J. Rabine, John C. Rabine, 2007, Current gastroenterology reports.

Diagnosis and management of supra-esophageal complications of reflux disease

T. Nostrant, J. Rabine, John C. Rabine, 2000 .

Successful use of an HMG-CoA reductase inhibitor as adjunctive therapy in the management of refractory bile leak complicating laparoscopic cholecystectomy.

Michael P. Jones, J. Rabine, 1998 .

Successful use of an HMG-CoA reductase inhibitor as adjunctive therapy in the management of refractory bile leak complicating laparoscopic cholecystectomy

Michael P. Jones, J. Rabine, 1998, American Journal of Gastroenterology.

4909 Radiofrequency energy application to the gastroesophageal junction for the treatment of gastroesophageal reflux disease.

J. DiBaise, N. Stollman, D. Utley, 2000 .

Management of the patient with gastroparesis.

J. Barnett, J. Rabine, 2001, Journal of clinical gastroenterology.

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease.

Peter J. Kahrilas, P. Kahrilas, Michael P. Jones, 2001 .

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease

Peter J Kahrilas, P. Kahrilas, Michael P. Jones, 2001, American Journal of Gastroenterology.

Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD.

D. Castell, G. Triadafilopoulos, J. DiBaise, 2001, Gastrointestinal endoscopy.

Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca® Procedure) for the treatment of fecal incontinence

J. Fleshman, E. Weiss, J. Efron, 2003, Diseases of the colon and rectum.

The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

D. Corley, R. Rothstein, M. Wolfe, 2002, Gastrointestinal endoscopy.

Hiatal hernia (HH) size is the principal determinant of esophagitis in patients with symptomatic gastroesophageal reflux disease

P. Kahrilas, Michael P. Jones, J. Rabine, 1998 .

The author reply

J. Fleshman, J. Efron, J. Nogueras, 2003 .